Acute therapy drugs, ones that have episodic use, had seen a sharp fall in demand once the pandemic hit. Chronic medicines such as anti-diabetic & cardiac drugs showed resilience as patients continued to refill prescriptions.
But a fall in doctor visits hit acute therapy drugs. July saw a major turnaround.
India Ratings Research analysis showed that therapies such as anti-infectives, analgesic mand respiratory drugs witnessed sales growth of 30.2 per cent YoY, 24.1 per cent YoY, and 22.8 per cent YoY, respectively.